Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Alaska for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Alaska only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Alaska (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Scott Limstrom (NPI 1366421885)

Field	Value
Entity Type	Individual
Organization	Scott Limstrom
Address	3500 La Touche
City	Anchorage
State	AK
ZIP	99508
Taxonomy	Ophthalmology Physician
NPI Enumerated	January 12, 2006

Payer Source	Total Paid
Medicare	$3.2M
Medicaid	$0

Key Findings

This provider is effectively single-payer for public programs: total Medicare revenue is $3.2M while there is no Medicaid billing on file. The absence of Medicaid claims means analyses of payer mix, access, or Medicaid-based volume are not supported by the available data and Medicare dominates this provider’s public reimbursement profile.

Revenue is highly concentrated in a small set of drug and injection codes: the precomputed top‑3 Medicare codes (J0178, J2777, 67028) account for 80.7% of this provider’s total Medicare revenue. Those three line items individually represent $1.7M (54.4%) for J0178, $607.4K (19.1%) for J2777, and $226.8K (7.1%) for 67028, signaling dependence on intravitreal therapeutics and related injection procedures for the bulk of public reimbursement.

The procedure and drug mix indicates a retina-focused ophthalmology practice with high utilization of intravitreal anti‑VEGF and related agents plus diagnostic imaging: J0178 (aflibercept) and J2777 (faricimab) are the top revenue drivers, J9035 (bevacizumab) also appears in the top 25, and 92134 (retinal OCT imaging) is a major diagnostic code. This combination is consistent with routine management of retinal disease (e.g., AMD, diabetic macular edema) where repeated injections and frequent imaging are central to the care model.

Competitive standing for the leading drug codes is high but not dominant nationally: J0178 ranks #321 of 3204 providers (90th percentile) and J2777 ranks #499 of 2039 providers (76th percentile), both labeled as "typical, unremarkable volume" despite being large revenue contributors for this clinician. In other drug categories J9035 ranks #249 of 1852 (87th percentile), again reflecting above‑average but not market‑leading positioning among national peers for these injected therapeutics.

There are clear statistical outliers in diagnostic and office-visit volume: 92134 (retinal imaging) ranks #251 of 26868 providers and is labeled an "extreme outlier, far above typical national volume," and 99213 (established office visit) ranks #5369 of 457151 providers and is also labeled an "extreme outlier." These rankings indicate unusually high imaging throughput and frequent established‑patient visits relative to national peer norms, suggesting a high-frequency care pathway for chronic retinal disease.

Surgical and other procedural work is present but represents a minority of Medicare revenue: cataract extraction with IOL insertion (66984) contributes $64.5K (2.0%) and ranks near the national median (#6934 of 15965, 56th percentile), while vitrectomy and retinal repair codes (e.g., 67041, 67108, 67036) appear at much smaller revenue shares. This pattern suggests the practice performs some surgical care but is predominantly structured around office‑based injections and imaging rather than high volumes of elective cataract or complex retinal surgery.

Operational profile shows varied claim/payment dynamics across drugs: J2777 posts 20.9K claims with an average paid/claim of $29 generating $607.4K, whereas J0178 posts 2.5K claims with an average paid/claim of $689 generating $1.7M. This contrast highlights a mix of very high‑frequency, low‑unit‑payment items and lower‑frequency, high‑unit‑payment biologics driving revenue, which has implications for inventory, billing workflows, and cash‑flow timing.

Provider tenure is long-standing: the NPI was enumerated on 2006-01-12 (~20 years ago), indicating an established clinical presence in Anchorage, AK. Long tenure can correlate with stable referral networks and sustained patient panels, which is consistent with the high recurring imaging and injection volumes observed in the Medicare data.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

25 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,510	$690	$1.7M
J2777	Injection, faricimab‑svoa, 0.1 mg	20,950	$30	$607.4K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,910	$120	$226.8K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,380	$40	$125.1K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,080	$80	$85K
66984	The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to…	130	$490	$64.5K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	390	$160	$61.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	450	$120	$52.1K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	410	$110	$44.5K
J9035	Injection, bevacizumab, 10 mg	520	$60	$29K

Showing 1–10 of 25

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 25 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Alaska Distribution

Scott Limstrom — 7 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Alaska

Full comparison — all codes billed, vs. state median

25 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	1	10	680	$690	$686.5K
J2777	1	10	8,400	$30	$320.4K
66984	13	60	40	$640	$86.7K
67028	1	10	390	$110	$65.8K
J7312	1	10	390	$160	$61.1K
67036	2	10	40	$1,500	$55.6K
67041	2	10	40	$1,470	$51.4K
67108	2	10	30	$1,520	$41.1K
J2781	1	10	180	$120	$21.7K
99214	93	1,210	90	$100	$16.2K

Showing 1–10 of 25

Related Providers

Other providers that share a Tax Identification Number (TIN) with Scott Limstrom, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Alaska Retinal Consultants	AK	Ophthalmology Physician	$0	$4.5M
Chad Bouchard	NY	Retina Specialist (Ophthalmology) Physician	$3.1M	$0
Matthew Guess	OH	Ophthalmology Physician	$2.8M	$0
David Zumbro	AK	Ophthalmology Physician	$67.2K	$0

Nearby Providers

Other providers in the same ZIP code as Scott Limstrom, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Alaska Native Tribal Health Consortium	AK	General Acute Care Hospital	$0	$397.1M
Providence Health & Services Washington	AK	General Acute Care Hospital	$0	$161.5M
Southcentral Foundation	AK	Community Health Clinic/Center	$0	$130.3M
Alaska Native Tribal Health Consortium	AK	Transportation Broker	$0	$65.5M
The Arc Of Anchorage	AK	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$50.8M
Good Samaritan Care Services	AK	In Home Supportive Care Agency	$0	$46.1M
Alaska Native Tribal Health Consortium	AK	General Acute Care Hospital	$0	$33.1M
Galen Hospital Alaska, Inc.	AK	General Acute Care Hospital	$0	$31.8M
Anchorage Community Mental Health	AK	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$31.7M
Patient Housing At Anmc	AK	General Acute Care Hospital	$0	$31M

Scott Limstrom — Billing Profile & Reimbursement Data

Sign up for Scott Limstrom — Billing Profile & Reimbursement Data policy alerts

Scott Limstrom — Billing Profile & Reimbursement Data

Sign up for Scott Limstrom — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References